grant

Combination Antifungals for Candida auris : using the hollow fibre model to study an azole/5FC combination for a WHO priority pathogen

Organization UKRILocation United Kingdom
UKRIUK ResearchGrantActive
Get Agency plan to apply$29.99/mo · 7-day free trial · pipeline · alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

Resistance to antibiotics is a major global health problem. The main focus has been on antibiotic resistance in bacteria, but drug resistance in fungal infections is a growing part of this problem.
This is typified by the emergence of a new species of pathogenic fungus. Called Candida auris, a type of harmful yeast discovered as recently as 2009…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Combination Antifungals for Candida auris : using the hollow fibre model to study an azole/5FC combination for a WHO pri | Dev Procure